Nicholas A.J. Botwood Syndax Pharmaceuticals Inc (SNDX) insider trading activity

SNDX Quotes by TradingView

Nicholas A.J. Botwood is Head of R&D, CMO of Syndax Pharmaceuticals Inc. Currently has a direct ownership of 35,165 shares of SNDX, which is worth approximately $392,441. The most recent transaction as insider was on May 16, 2025, when has been sold 11,765 shares (Common Stock) at a price of $8.99 per share, resulting in proceeds of $105,767. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 35.2K
n/a 3M change
n/a 12M change
Total Value Held $392,441

Nicholas A.J. Botwood Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 16 2025
BUY
Open market or private purchase
$105,767 $8.99 p/Share
11,765 Added 25.07%
35,165 Common Stock
NAB

Nicholas A.J. Botwood

Head of R&D, CMO
New York, NY

Track Institutional and Insider Activities on SNDX

Follow Syndax Pharmaceuticals Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SNDX shares.

Notify only if

Insider Trading

Get notified when an Syndax Pharmaceuticals Inc insider buys or sells SNDX shares.

Notify only if

News

Receive news related to Syndax Pharmaceuticals Inc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SNDX